Ariana M. Chao

Consensus-based clinical and research recommendations for use of glucagon-like peptide-1 receptor agonists in the context of eating disorders: a modified Delphi study.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for type 2 diabetes management and later expanded to obesity treatment, have shown preliminary efficacy in reducing binge eating episodes. However, the appetite-suppressing and weight-loss effects of GLP-1R...

Plain language review: non-invasive screening for metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic dysfunction–associated steatohepatitis (MASH) in primary care

Plain Language SummaryWhat is this summary about?Metabolic dysfunction–associated steatotic liver disease, or MASLD, and its severe form, metabolic dysfunction–associated steatohepatitis, or MASH, impose significant global burdens on patients and healthcare systems. It is importa...